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Introduction
Elder financial exploitation (EFE,) defined as the illegal or improper use 
of the property or resources of an incapacitated or dependent adult for 
another’s profit or advantage, takes myriad forms such as scams 
perpetrated by strangers or frauds perpetrated by trusted advisors.  
Most often however, EFE involves family members or friends who take 
or divert money or property for their own use.  The loss of resources can 
lead to an older adult’s inability to meet their own needs for food, 
shelter, or health care and increase their reliance on public programs, 
which often pay for these services for vulnerable adults. 
This study sought to determine the Medicare and Medicaid costs 
experienced by dual eligible older adults in Maine for whom Maine 
Adult Protective Services (APS) substantiated allegations of EFE and to 
compare them to those of Maine’s general older population. The 
analysis is an important step forward in estimating the medical costs 
associated with elder abuse. 
Data Sources and Study Design
• The primary sources of data for this study are Medicare summary 
enrollment, cost, use, and chronic and disabling conditions data 
files; Maine Medicaid administrative claims; and Maine Adult 
Protective Services Information System (MAPSIS) data. All three 
data sources were limited to Maine adults age 60 and older over 
years 2006-2014.
• Dual eligible adults with APS investigations of EFE in 2007-2012 
were matched with a set of non-APS controls. We established a 4-
year study period for each APS adult: 1 pre-APS event year; the APS 
event year; and 2 years following the APS event year.  Propensity 
scores facilitated matching each APS-EFE adult to 2 non-APS 
controls using nearest kernel techniques. Members were matched 
using age, gender, number and type of chronic conditions, payer 
(i.e. dual eligible), and urban/rural residence based on Rural-Urban 
Commuting Area codes. 
• Using  a quasi-experimental design, difference in differences logistic 
models and generalized linear models addressed the impact of 
financial exploitation on the probability of incurring costs and levels 
of inpatient, outpatient, long term services and supports (LTSS), 
and prescription expenditures, respectively.
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Research Questions
1. What is the socioeconomic and health status profile of victims of 
EFE; how do they compare to the general older population in Maine?
2. Does the health care cost(use) profile of victims of EFE change pre & 
post APS investigation; how does this compare to matched controls?
3. Does health care use and cost differ from that of the general 
population by type of utilization, i.e. by inpatient, outpatient, LTSS, 
and prescription services?
Summary of Results
Results
Figure 1. Total (observed) per member per month expenditures for APS-EFE 
and non-APS matched controls across 4-year study period, with upper and 
lower 95% confidence intervals
Conclusion
Table 2.  Difference in differences generalized linear model (Gamma distribution 
with identity link) estimating total expenditure levels (including inpatient, 
outpatient, LTSS, and prescription services), 2006-14*
Total Costs 
(n=1,640 person-years)
$ Coefficient $ Robust SE P>|z| $ LL 95% CI $ UL 95% CI
Group (APS = 1) 543 240 0.02 73 1,013
Year 2 149 101 0.14 -49 348
Year 3 413 137 0.003 144 682
Year 4 752 151 0 455 1,048
Group X Year 2 511 212 0.02 97 926
Group X Year 3 578 265 0.03 59 1,098
Group X Year 4 708 359 0.05 4 1,412
Baseline Costs 1,682 144 0 1,400 1,963
SE=Standard Error, LL=Lower Limit, UL=Upper Limit, CI=Confidence Interval
Table 3. Total 4-year Medicare and Medicaid costs above matched controls for 131 
dual eligible older adults with substantiated elder financial exploitation
PMPM by year costs above expected PMPM in the 
absence of substantiated abuse
Per member annual cost
(PMPM*12)
Y1  $543 $6,516
Y2  $511 $6,132
Y3  $578 $6,936
Y4  $708 $8,496
Total per member cost above expected over four year 
study period (SUM Y1:Y4)
$28,080
4-year costs of 131 substantiated abuse cases above 
expected costs absent abuse (131*$28,080)
$3.7 million
Note: Costs are standardized to 2014 dollars.
A higher proportion of the APS-EFE group lived in rural areas compared to the non-APS 
comparison pool (47% vs. 44%). Geographic isolation can lead to greater dependence on 
others for daily needs and provide opportunities for exploitation to occur. 
The APS-EFE population represent a more vulnerable, clinically complex set of patients:  
they had a higher number of chronic conditions, were more likely to have been diagnosed 
with Alzheimer’s Disease and other dementia, asthma, heart disease, cancer, depression, 
diabetes, chronic kidney disease, and stroke than the general elderly population.
The APS-EFE group had higher total costs than matched controls across the 4-year study 
period. While annual costs for both groups increased over time, difference in differences 
generalized linear model showed the interaction between Years 2-4 and baseline to be 
significantly higher for the APS-EFE group (p  < 0.05). Strikingly, the APS-EFE group were 
nearly twice as likely to be hospitalized (p=0.003) and for those who were, hospitalization 
costs were an estimated $797 higher than controls (p=0.04). 
Compared to matched controls, the APS-EFE group had higher costs over the 4-year study 
period of nearly $3.7 million, 2006-2014. 
Elder financial exploitation may result in significant public burden on Medicare and 
Medicaid, shouldered by taxpayers. Efforts to detect, investigate, prosecute, and 
mitigate this abuse will benefit not only the victims, but also the financial stewardship 
of these public programs. 
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Pre-Period APS Event Year Post-Year 1 Post-Year 2
APS-EFE
N=131
Non-APS
N=281
Characteristic
APS-EFE
N=131
Non-APS 
N=69,432
P-value
Age (Avg. years) 76.8 73.8 0.54
% Less than 75 40.5 54.8
0.004% 75 to 84 38.9 30.4
% 85 and older 20.6 14.9
% Female 66.4 63.8 0.54
Health Status – Chronic Conditions
Avg. no. of chronic conditions 9.4 6.7 0.0001
Alzheimer’s / Dementia 67.94 22.35 0.0001
AMI 14.50 9.03 0.03
Anemia 83.97 54.01 0.0001
Asthma 25.95 15.81 0.002
Atrial Fibrillation 29.01 20.16 0.01
Bipolar Disorder 10.69 5.15 0.004
Cancer 27.48 16.74 0.001
Congestive Heart Failure 64.89 35.11 0.0001
Chronic Obstructive Pulmonary Disorder 61.07 40.07 0.0001
Depression 77.86 46.98 0.0001
Diabetes 64.12 41.26 0.0001
Ischemic Heart Disease 61.83 51.36 0.02
Chronic Kidney Disease 59.54 35.63 0.0001
Stroke 29.01 16.15 0.0001
Rural-Urban Commuting Areas
% Urban 53.4 55.6
0.12
% Large rural 17.6 12.3
% Small rural 8.4 13.5
% Isolated 20.6 18.5
Table 2. Characteristics of APS-EFE and Non-APS Sample Populations 
